Found: 6
Select item for more details and to access through your institution.
Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127976
- By:
- Publication type:
- Article
The expression of ATF3, MMP-2 and maspin in tissue chip of glioma.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2015, v. 28, p. 1059
- By:
- Publication type:
- Article
Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2015, v. 28, p. 359
- By:
- Publication type:
- Article
Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells.
- Published in:
- Oncology Letters, 2021, v. 21, n. 5, p. N.PAG, doi. 10.3892/ol.2021.12636
- By:
- Publication type:
- Article
Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells.
- Published in:
- Oncology Letters, 2015, v. 10, n. 5, p. 3266, doi. 10.3892/ol.2015.3699
- By:
- Publication type:
- Article
Activating transcription factor 3 is overexpressed in human glioma and its knockdown in glioblastoma cells causes growth inhibition both in vitro and in vivo.
- Published in:
- International Journal of Molecular Medicine, 2015, v. 35, n. 6, p. 1561, doi. 10.3892/ijmm.2015.2173
- By:
- Publication type:
- Article